skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

European journal of heart failure, 2019-10, Vol.21 (10), p.1270-1278 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1536 ;PMID: 31584231

Digital Resources/Online E-Resources

Citations Cited by

Searching Remote Databases, Please Wait